Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124249) titled 'A Multicenter Clinical Study on AI-Powered Precision Decision-Making Management for Pancreatic Diseases Using Contrast-Enhanced CT' on May 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: ShangHai ChangHai Hospital
Condition:
pancreatic cancer
Intervention:
AI group:None
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-05-11
Target Sample Size: AI group:6740;Clinicians group:6740;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=321770
Published by HT Digital Content Services with permission fr...